In contrast, male Cyp2b-null mice are more susceptible to liver damage and hepatic steatosis with no changes in fibrosis or inflammation markers between CDAHFD-fed WT and Cyp2b-null mice. Here, CYP2B6 is linked to fatty liver disease.